These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12965105)

  • 21. Insulin allergy and extensive lipoatrophy in child with type 1 diabetes.
    Beltrand J; Guilmin-Crepon S; Castanet M; Peuchmaur M; Czernichow P; Levy-Marchal C
    Horm Res; 2006; 65(5):253-60. PubMed ID: 16582568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generalized allergy due to zinc in insulin treated with zinc-free insulin.
    Ben Ammar I; Ksouri H; Trabelsi N; Mellouli F; Ben Mami F; Dakhli S; Achour A
    Acta Diabetol; 2012 Jun; 49(3):239-41. PubMed ID: 20963448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic allergy to human insulin and its rapid and long acting analogs: successful treatment by continuous subcutaneous insulin lispro infusion.
    Castéra V; Dutour-Meyer A; Koeppel M; Petitjean C; Darmon P
    Diabetes Metab; 2005 Sep; 31(4 Pt 1):391-400. PubMed ID: 16369203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immediate-type human insulin allergy successfully treated by continuous subcutaneous insulin infusion.
    Nagai T; Nagai Y; Tomizawa T; Mori M
    Intern Med; 1997 Aug; 36(8):575-8. PubMed ID: 9260776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glargine and lispro: two cases of mistaken identity.
    Adlersberg MA; Fernando S; Spollett GR; Inzucchi SE
    Diabetes Care; 2002 Feb; 25(2):404-5. PubMed ID: 11815523
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical use of long-acting insulin analogs].
    Birkeland KI
    Tidsskr Nor Laegeforen; 2006 Apr; 126(8):1067-8. PubMed ID: 16619068
    [No Abstract]   [Full Text] [Related]  

  • 27. A practical, clinical approach to the assessment and management of suspected insulin allergy.
    Jacquier J; Chik CL; Senior PA
    Diabet Med; 2013 Aug; 30(8):977-85. PubMed ID: 23601039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resolution of lipohypertrophy following change of short-acting insulin to insulin lispro (Humalog).
    Roper NA; Bilous RW
    Diabet Med; 1998 Dec; 15(12):1063-4. PubMed ID: 9868982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The human insulin analogue aspart is not the almighty solution for insulin allergy.
    Takata H; Kumon Y; Osaki F; Kumagai C; Arii K; Ikeda Y; Suehiro T; Hashimoto K
    Diabetes Care; 2003 Jan; 26(1):253-4. PubMed ID: 12502700
    [No Abstract]   [Full Text] [Related]  

  • 30. Hyperpigmentation due to insulin allergy.
    Neki NS; Gupta SN; Mani T; Gupta H
    Natl Med J India; 2014; 27(3):183. PubMed ID: 25668097
    [No Abstract]   [Full Text] [Related]  

  • 31. Allergic reactions to human insulin: a review of current knowledge and treatment options.
    Akinci B; Yener S; Bayraktar F; Yesil S
    Endocrine; 2010 Feb; 37(1):33-9. PubMed ID: 19876775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anaphylaxis to subcutaneous neutral protamine Hagedorn insulin with simultaneous sensitization to protamine and insulin.
    Blanco C; Castillo R; Quiralte J; Delgado J; García I; de Pablos P; Carrillo T
    Allergy; 1996 Jun; 51(6):421-4. PubMed ID: 8837667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A case of lipoatrophy with Lispro insulin without insulin pump therapy.
    Arranz A; Andia V; López-Guzmán A
    Diabetes Care; 2004 Feb; 27(2):625-6. PubMed ID: 14747261
    [No Abstract]   [Full Text] [Related]  

  • 34. Insulin lispro: a review of its pharmacological properties and therapeutic use in the management of diabetes mellitus.
    Wilde MI; McTavish D
    Drugs; 1997 Oct; 54(4):597-614. PubMed ID: 9339963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe insulin allergy successfully treated with continuous subcutaneous insulin infusion.
    Fujikawa T; Imbe H; Date M; Go Y; Kitaoka H
    Diabetes Res Clin Pract; 2012 Aug; 97(2):e31-3. PubMed ID: 22609054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advantage of insulin lispro in suspected insulin allergy.
    Pánczél P; Hosszúfalusi N; Horváth MM; Horváth A
    Allergy; 2000 Apr; 55(4):409-10. PubMed ID: 10782533
    [No Abstract]   [Full Text] [Related]  

  • 37. Type I allergy to insulin: case report and review of localized and systemic reactions to insulin.
    Hoffman AG; Schram SE; Ercan-Fang NG; Warshaw EM
    Dermatitis; 2008; 19(1):52-8. PubMed ID: 18346398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human insulin allergy-immediate and late type III reactions in a long-standing IDDM patient.
    Silva ME; Mendes MJ; Ursich MJ; Rocha DM; Brito AH; Fukui RT; Ruggeri GB; Nery M; Wajchenberg BL
    Diabetes Res Clin Pract; 1997 May; 36(2):67-70. PubMed ID: 9229189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of adolescents with type 1 diabetes mellitus.
    Garg S; Chase HP
    J Pediatr Endocrinol Metab; 2004 May; 17(5):805-6. PubMed ID: 15237718
    [No Abstract]   [Full Text] [Related]  

  • 40. Insulin aspart: a review of its use in the management of type 1 and 2 diabetes mellitus.
    Chapman TM; Noble S; Goa KL
    Drugs; 2002; 62(13):1945-81. PubMed ID: 12215068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.